Effects of thyroid hormone status on metabolic pathways of arachidonic acid in mice and humans: A targeted metabolomic approach

Prostaglandins and Other Lipid Mediators

Volumn 118-119, Issue , 2015, Pages 11-18

  Yao, Xuan ^a,b,c   Sa, Rina ^a,b   Ye, Cheng ^a,b   Zhang, Duo ^a,b   Zhang, Shengjie ^a,b   Xia, Hongfeng ^a,b   Wang, Yu cheng ^c,d   Jiang, Jingjing ^e   Yin, Huiyong ^a,b   Ying, Hao ^a,b,c  

^a UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^b BEIJING HOSPITAL   (China)

^c Chinese Academy of Sciences   (China)

^d Shanghai Xuhui Central Hospital   (China)

^e FUDAN UNIVERSITY   (China)

Author keywords

Arachidonic acid metabolites; Cardiovascular disorders; Hyperthyroidism; Hypothyroidism; Targeted metabolomic approach

Indexed keywords

11 DEHYDRO THROMBOXANE B2; 12 HYDROXYICOSATETRAENOIC ACID; 13 HYDROXYOCTADECADIENOIC ACID; 15 HYDROXYICOSATETRAENOIC ACID; 2,3 DINOR 6 KETO PROSTAGLANDIN F1 ALPHA; 20 HYDROXYICOSATETRAENOIC ACID; 5 HYDROXYICOSATETRAENOIC ACID; 9 HYDROXYOCTADECADIENOIC ACID; ARACHIDONIC ACID; CYTOCHROME P450; DIHYDROXYEICOSATRIENOIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSANOID; LINOLEIC ACID; LIOTHYRONINE; LIOTRIX; LIPOXYGENASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROSTACYCLIN; PROSTACYCLIN I2; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; THROMBOXANE; THROMBOXANE A2; THYROID HORMONE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; THROMBOXANE B2;

ADULT; ANIMAL MODEL; ARACHIDONIC ACID METABOLISM; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; FREE THYROXINE INDEX; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; LIOTHYRONINE BLOOD LEVEL; MALE; MASS SPECTROMETRY; METABOLITE; MOUSE; NONHUMAN; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; PULSE PRESSURE; SIGNAL TRANSDUCTION; TRIACYLGLYCEROL BLOOD LEVEL; URINE LEVEL; ANIMAL; BLOOD; BLOOD PRESSURE; C57BL MOUSE; METABOLISM; METABOLOMICS; MIDDLE AGED; PATHOPHYSIOLOGY; YOUNG ADULT;

ADULT; ANIMALS; ARACHIDONIC ACID; BLOOD PRESSURE; DINOPROSTONE; FEMALE; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; LINOLEIC ACID; MALE; METABOLIC NETWORKS AND PATHWAYS; METABOLOMICS; MICE, INBRED C57BL; MIDDLE AGED; THROMBOXANE B2; THYROID HORMONES; YOUNG ADULT;

EID: 84927134077     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2015.03.005     Document Type: Article

References (37)

1. I. Klein, and K. Ojamaa Mechanisms of disease: thyroid hormone and the cardiovascular system New Engl J Med 344 7 2001 501 509
2. P.M. Yen Physiological and molecular basis of thyroid hormone action Physiol Rev 81 3 2001 1097 1142
3. M. Helfand, and C.C. Redfern Clinical guideline, part 2. Screening for thyroid disease: an update. American College of Physicians Ann Intern Med 129 2 1998 144 158
4. M.I. Surks, E. Ortiz, and G.H. Daniels et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management JAMA 291 2 2004 228 238
5. W.M.G. Tunbridge, D.C. Evered, and R. Hall et al. Spectrum of thyroid disease in a community - Whickham survey Clin Endocrinol 7 6 1977 481 493
6. M.P.J. Vanderpump, W.M.G. Tunbridge, and J.M. French et al. The Incidence of thyroid-disorders in the community - a 20-year follow-up of the Whickham survey Clin Endocrinol 43 1 1995 55 68
7. G.J. Canaris, N.R. Manowitz, G. Mayor, and E.C. Ridgway The Colorado thyroid disease prevalence study Arch Intern Med 160 4 2000 526 534
8. A.R. Cappola, and P.W. Ladenson Hypothyroidism and atherosclerosis J Clin Endocr Metab 88 6 2003 2438 2444
9. L.M. Prisant, J.S. Gujral, and A.L. Mulloy Hyperthyroidism: a secondary cause of isolated systolic hypertension J Clin Hypertens 8 8 2006 596 599
10. M. Marvisi, P. Zambrelli, M. Brianti, G. Civardi, R. Lampugnani, and R. Delsignore Pulmonary hypertension is frequent in hyperthyroidism and normalizes after therapy Eur J Intern Med 17 4 2006 267 271
11. I. Klein, and S. Danzi Thyroid disease and the heart Circulation 116 15 2007 1725 1735
12. E.M. Smyth, T. Grosser, M. Wang, Y. Yu, and G.A. FitzGerald Prostanoids in health and disease J Lipid Res 50 Suppl 2009 S423 S428
13. J. Kawabe, F. Ushikubi, and N. Hasebe Prostacyclin in vascular diseases - recent insights and future perspectives Circ J 74 5 2010 836 843
14. J.M. Williams, S. Murphy, M. Burke, and R.J. Roman 20-Hydroxyeicosatetraeonic acid: a new target for the treatment of hypertension J Cardiovasc Pharm 56 4 2010 336 344
15. W.K. Lin, J.R. Falck, and P.Y. Wong Effect of 14,15-epoxyeicosatrienoic acid infusion on blood pressure in normal and hypertensive rats Biochem Biophys Res Commun 167 3 1990 977 981
16. J. Bellien, and R. Joannides Epoxyeicosatrienoic acid pathway in human health and diseases J Cardiovasc Pharmacol 61 3 2013 188 196
17. A.M. Zavacki, H. Ying, and M.A. Christoffolete et al. Type 1 iodothyronine deiodinase is a sensitive marker of peripheral thyroid status in the mouse Endocrinology 146 3 2005 1568 1575
18. Y. Song, S. Shan, and Y. Zhang et al. Ligand-dependent corepressor acts as a novel corepressor of thyroid hormone receptor and represses hepatic lipogenesis in mice J Hepatol 56 1 2012 248 254
19. X. Yao, S. Hou, and D. Zhang et al. Regulation of fatty acid composition and lipid storage by thyroid hormone in mouse liver Cell Biosci 4 2014 38
20. Y.J. Huang, M.J. Zhu, and Z. Li et al. Mass spectrometry-based metabolomic profiling identifies alterations in salivary redox status and fatty acid metabolism in response to inflammation and oxidative stress in periodontal disease Free Radical Bio Med 70 2014 223 232
21. W.L. Song, J.A. Lawson, M. Wang, H. Zou, and G.A. FitzGerald Noninvasive assessment of the role of cyclooxygenases in cardiovascular health: a detailed HPLC/MS/MS method Methods Enzymol 433 2007 51 72
22. A.R. Cappola, and P.W. Ladenson Hypothyroidism and atherosclerosis J Clin Endocrinol Metab 88 6 2003 2438 2444
23. S. Fazio, E.A. Palmieri, G. Lombardi, and B. Biondi Effects of thyroid hormone on the cardiovascular system Recent Prog Horm Res 59 2004 31 50
24. L. Frost, P. Vestergaard, and L. Mosekilde Hyperthyroidism and risk of atrial fibrillation or flutter: a population-based study Arch Intern Med 164 15 2004 1675 1678
25. C.D. Funk Prostaglandins and leukotrienes: advances in eicosanoid biology Science 294 5548 2001 1871 1875
26. A. Sarkis, B. Lopez, and R.J. Roman Role of 20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids in hypertension Curr Opin Nephrol Hypertens 13 2 2004 205 214
27. C.D. Funk, and T. Cyrus 12/15-lipoxygenase, oxidative modification of LDL and atherogenesis Trends Cardiovas Med 11 3-4 2001 116 124
28. R.J. Roman P-450 metabolites of arachidonic acid in the control of cardiovascular function Physiol Rev 82 1 2002 131 185
29. M. Sasaki, M.T. Hori, T. Hino, M.S. Golub, and M.L. Tuck Elevated 12-lipoxygenase activity in the spontaneously hypertensive rat Am J Hypertens 10 4 Pt 1 1997 371 378
30. D. Gonzalez-Nunez, J. Claria, F. Rivera, and E. Poch Increased levels of 12(S)-HETE in patients with essential hypertension Hypertension 37 2 2001 334 338
31. N.A. Flavahan Balancing prostanoid activity in the human vascular system Trends Pharmacol Sci 28 3 2007 106 110
32. Y. Huo, and K.F. Ley Role of platelets in the development of atherosclerosis Trends Cardiovasc Med 14 1 2004 18 22
33. M. Vinals, J. Martinez-Gonzalez, J.J. Badimon, and L. Badimon HDL-induced prostacyclin release in smooth muscle cells is dependent on cyclooxygenase-2 (Cox-2) Arterioscl Thromb Vas 17 12 1997 3481 3488
34. S. Gross, P. Tilly, D. Hentsch, J.L. Vonesch, and J.E. Fabre Vascular wall-produced prostaglandin E2 exacerbates arterial thrombosis and atherothrombosis through platelet EP3 receptors J Exp Med 204 2 2007 311 320
35. D. Elstein, A. Nir, M. Klutstein, B. Rudensky, and A. Zimran C-reactive protein and NT-proBNP as surrogate markers for pulmonary hypertension in Gaucher disease Blood Cells Mol Dis 34 3 2005 201 205
36. K.G. Blyth, B.A. Groenning, and P.B. Mark et al. NT-proBNP can be used to detect right ventricular systolic dysfunction in pulmonary hypertension Eur Respir J 29 4 2007 737 744
37. F. Liu, J.Y. Wu, D. Beasley, and J.A. Orr TxA(2)-induced pulmonary artery contraction requires extracellular calcium Resp Physiol 109 2 1997 155 166